Avalo Therapeutics Inc
F:C6K0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Avalo Therapeutics Inc
F:C6K0
|
US |
|
O
|
Organon & Co
F:7XP
|
US |
|
C
|
China Longyuan Power Group Corp Ltd
F:6WX
|
CN |
Wall St Price Targets
C6K0 Price Targets Summary
Avalo Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
C6K0 is 33.32 EUR with a low forecast of 24.57 EUR and a high forecast of 45.25 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is C6K0's stock price target?
Price Target
33.32
EUR
According to Wall Street analysts, the average 1-year price target for
C6K0 is 33.32 EUR with a low forecast of 24.57 EUR and a high forecast of 45.25 EUR.
What is the Revenue forecast for Avalo Therapeutics Inc?
Projected CAGR
227%
Over the last 13 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 8 years is 227%.